• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌三野淋巴结清扫术后复发模式及相关复发预测因素。

Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.

机构信息

First Hospital of Quanzhou Affiliated to Fujian Medical University, 362000 Quanzhou, People's Republic of China.

The Teaching Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, 350000 Fuzhou, People's Republic of China.

出版信息

Cancer Radiother. 2023 May;27(3):189-195. doi: 10.1016/j.canrad.2022.09.001. Epub 2023 Feb 6.

DOI:10.1016/j.canrad.2022.09.001
PMID:36754752
Abstract

PURPOSE

For treatment of esophageal carcinoma, the optimal postoperative radiotherapy target volume after three-field lymph node dissection (3-FLD) had not been determined. We analyzed local recurrence pattern of thoracic esophageal carcinoma and risk factors of lymph node recurrence after 3-FLD without prophylactic radiotherapy.

MATERIAL AND METHODS

We reviewed 1282 patients with thoracic esophageal squamous cell carcinoma (ESCC) who were treated with 3-FLD without radiotherapy from 2010 to 2018 and analysed local recurrence patterns and risk factors of lymph node recurrence, in order to provide a reference for determination of the radiotherapy target volume for thoracic ESCC.

RESULTS

The lymph node recurrence accounted for 91.0% of treatment failures. The mediastinal, cervical and abdominal lymph node recurrence accounted for 84.92%, 36.07% and 22.30%, respectively (χ=264.776, P=0.000). The superior, middle and inferior mediastinal lymph node recurrence rates were 67.54%, 27.87% and 0.98%, respectively (χ=313.600, P=0.000). Cervical metastases were significantly associated with N stage and Preoperative cervical lymph node status. Abdominal metastases were significantly associated with the number of preoperative abdominal lymph node metastases (LNM), tumor location and N stage.

CONCLUSIONS

The main pattern of local-regional recurrence might be lymph node metastasis after radical 3-FLD without radiotherapy in esophageal carcinoma. The dangerous lymph node recurrence regions included neck, superior and middle mediastinum. The abdominal areas might be irradiated for lower TEC patients with preoperative abdominal LNM.

摘要

目的

对于食管癌的治疗,在进行三野淋巴结清扫(3-FLD)后,最佳的术后放疗靶区尚未确定。我们分析了未行预防性放疗的 3-FLD 后胸段食管鳞癌(ESCC)的局部复发模式和淋巴结复发的危险因素。

材料与方法

我们回顾了 2010 年至 2018 年间,1282 例接受 3-FLD 治疗但未接受放疗的胸段 ESCC 患者,分析了局部复发模式和淋巴结复发的危险因素,以期为胸段 ESCC 的放疗靶区确定提供参考。

结果

淋巴结复发占治疗失败的 91.0%。纵隔、颈部和腹部淋巴结复发分别占 84.92%、36.07%和 22.30%(χ²=264.776,P=0.000)。上、中、下纵隔淋巴结复发率分别为 67.54%、27.87%和 0.98%(χ²=313.600,P=0.000)。颈部转移与 N 分期和术前颈部淋巴结状态显著相关。腹部转移与术前腹部淋巴结转移(LNM)的数量、肿瘤位置和 N 分期显著相关。

结论

根治性 3-FLD 后不进行放疗的食管癌主要局部复发模式可能是淋巴结转移。危险的淋巴结复发区域包括颈部、上纵隔和中纵隔。对于术前有腹部 LNM 的低 T 期 ESCC 患者,腹部区域可能需要进行放疗。

相似文献

1
Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.食管癌三野淋巴结清扫术后复发模式及相关复发预测因素。
Cancer Radiother. 2023 May;27(3):189-195. doi: 10.1016/j.canrad.2022.09.001. Epub 2023 Feb 6.
2
Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.接受三野淋巴结清扫术的胸段食管癌患者的淋巴结转移模式
Eur Surg Res. 2007;39(1):1-6. doi: 10.1159/000096925. Epub 2006 Nov 10.
3
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.在根治性食管切除术和三野淋巴结清扫术后,颈淋巴结转移在胸段食管鳞状细胞癌中被归类为区域淋巴结分期。
BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.
4
[Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].[两野淋巴结清扫食管切除术治疗胸段pT3N0M0期食管鳞状细胞癌患者的复发模式]
Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):48-54. doi: 10.3760/cma.j.issn.0253-3766.2016.01.010.
5
Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma: a retrospective cohort study.胸段食管鳞癌根治性切除术后淋巴结复发的精确部位描述与处理:一项回顾性队列研究。
Int J Surg. 2024 Jun 1;110(6):3440-3449. doi: 10.1097/JS9.0000000000001242.
6
Patterns of Regional Lymph Node Recurrence After Radical Surgery for Thoracic Esophageal Squamous Cell Carcinoma.胸段食管鳞状细胞癌根治术后区域淋巴结复发模式
Ann Thorac Surg. 2016 Feb;101(2):551-7. doi: 10.1016/j.athoracsur.2015.08.057. Epub 2015 Oct 31.
7
Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.食管癌2野与3野淋巴结清扫的短期疗效比较。
Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox096.
8
Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.双侧锁骨上区术后放疗对胸段中下段食管癌的疗效
World J Gastroenterol. 2014 Dec 21;20(47):17970-5. doi: 10.3748/wjg.v20.i47.17970.
9
[Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].[pT1bN0M0 - pT4aN0M0期胸段食管鳞状细胞癌术后复发和转移的相关因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):1045-1049.
10
Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.基于淋巴结转移模式的 T1b/T2 胸段食管鳞癌临床靶区勾画意义。
Future Oncol. 2019 Oct;15(29):3345-3355. doi: 10.2217/fon-2019-0266. Epub 2019 Oct 3.

引用本文的文献

1
Variables related to locoregional and distant recurrence in esophageal cancer.与食管癌局部区域及远处复发相关的变量。
Arq Bras Cir Dig. 2025 Aug 4;38:e1889. doi: 10.1590/0102-67202025000020e1889. eCollection 2025.
2
A dynamic nomogram for predicting abdominal lymph node recurrence in patients with esophageal carcinoma.一种用于预测食管癌患者腹部淋巴结复发的动态列线图。
Sci Rep. 2025 Apr 18;15(1):13412. doi: 10.1038/s41598-025-97774-x.
3
Postoperative adjuvant immunotherapy for pathological stage II-IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates.
根治性手术后,病理分期为II-IVa期的食管鳞状细胞癌患者接受术后辅助免疫治疗并不能提高无病复发率。
Front Med (Lausanne). 2024 Dec 13;11:1517001. doi: 10.3389/fmed.2024.1517001. eCollection 2024.